Evidence map›Paper›PMID 39272709›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Capillary Leak Syndrome Associated with Anaplastic T Cell Lymphoma and Transcutaneous Exudation: An Unusual Presentation.

Radu Andrei Tomai, Antonia Oancea, Ciprian Tomuleasa, Delia Dima

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Radu Andrei TomaiDepartment of Haematology, "Ion Chiricuta" Institute of Oncology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
Antonia OanceaDepartment of Haematology, "Ion Chiricuta" Institute of Oncology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
Ciprian TomuleasaDepartment of Haematology, "Ion Chiricuta" Institute of Oncology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-5500-1519
Delia DimaDepartment of Haematology, "Ion Chiricuta" Institute of Oncology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-5330-265X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capillary leak syndrome is a rare complication of cancer, particularly of hematologic malignancies. The syndrome was first described as an idiopathic entity; however, increasingly, more cases are being reported in association with cancers and other conditions. Diagnosis stems from the recognition of the double paradox, consisting of severe generalized oedema and hypotension, accompanied by hallmark laboratory modifications. Concurrent conditions in patients with malignancies can alter laboratory findings and make the diagnosis a challenge. This report presents the case of a patient with capillary leak syndrome and an atypical presentation, with generalized skin rash and transcutaneous exudation occurring concurrently with anaplastic large T cell lymphoma, macrophage activation syndrome, and cytopenias. Symptom-specific treatment with diuretics and albumin was ineffective in the case of our patient; however, the CLS remitted promptly with cancer-specific therapy. No treatment has proved to be generally effective against CLS up to date, as is the case for this patient. Thus, the rapid recognition of cancer-associated capillary leak syndrome and the initiation of cancer-specific treatment proves to be the better approach and is key to avoiding unnecessary delays and ineffective treatments targeted specifically at CLS.

Indexed as

capillary leak syndromeT-cell lymphomaunusual presentation

Identifiers

PMID39272709
PMCPMC11394617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.